Financhill
Back

Haemonetics Quote, Financials, Valuation and Earnings

Haemonetics Price Quote

$84.95
-0.01 (0.97%)
(Updated: July 6, 2024 at 5:45 AM ET)

Haemonetics Key Stats

Buy
63
Haemonetics (HAE) is a Buy

Day range:
$83.86 - $85.02
52-week range:
$70.74 - $97.97
Dividend yield:
0%
P/E ratio:
37.10
P/S ratio:
3.34
P/B ratio:
4.51%

Volume:
320.4K
Avg. volume:
761.2K
1-year change:
1.23%
Market cap:
$4.3B
Revenue:
$1.3B
EPS:
$2.29

How Much Does Haemonetics Make?

  • How Much Are Haemonetics's Sales Annually?
    HAE Revenues are $1.3B
  • How Much Profit Does Haemonetics's Make A Year?
    HAE net income is $117.6M

Is Haemonetics Growing As A Company?

  • What Is Haemonetics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.13%
  • What Is Haemonetics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is -0.3%

Haemonetics Stock Price Performance

  • Did Haemonetics Stock Go Up Last Month?
    Haemonetics share price went down by -4.38% last month
  • Did HAE's Share Price Rise Over The Last Year?
    HAE share price rose by 1.23% over the past 1 year

What Is Haemonetics 52-Week High & Low?

  • What Is Haemonetics’s 52-Week High Share Price?
    Haemonetics has traded as high as $97.97 over the past 52 weeks
  • What Is Haemonetics’s 52-Week Low Share Price?
    Haemonetics has traded as low as $70.74 over the past 52 weeks

Haemonetics Price To Free Cash Flow

Is It Risky To Buy Haemonetics?

  • How Much Debt Does Haemonetics Have?
    Total long term debt quarterly is $807.8M
  • How Much Cash Does Haemonetics Have?
    Cash and short term investments quarterly total is $178.8M
  • What Is Haemonetics’s Book Value Per Share?
    Book value per share is 18.90

Is Haemonetics Cash Flow Positive?

  • What Is HAE Cash Flow From Operations?
    Cash flow from operations (TTM) is $181.8M
  • What Is Haemonetics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $38.2M
  • What Is Haemonetics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$322.4M

Haemonetics Return On Invested Capital

  • Is Management Doing A Good Job?
    HAE return on invested capital is 6.96%
  • What Is Haemonetics Return On Assets?
    ROA measures how assets are converting to revenues and is 5.7%
  • What Is HAE Return On Equity?
    ROE is a measure of profitability and is 13.12%

Haemonetics Earnings Date & Stock Price

  • What Is Haemonetics's Stock Price Today?
    A single share of HAE can be purchased today for 84.96
  • What Is Haemonetics’s Stock Symbol?
    Haemonetics trades on the nyse under the ticker symbol: HAE
  • When Is Haemonetics’s Next Earnings Date?
    The next quarterly earnings date for Haemonetics is scheduled on August 8, 2024
  • When Is HAE's next ex-dividend date?
    Haemonetics's next ex-dividend date is July 7, 2024
  • How To Buy Haemonetics Stock?
    You can buy Haemonetics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

Haemonetics Competitors

  • Who Are Haemonetics's Competitors?
    Below is a list of companies who compete with Haemonetics or are related in some way:
    • Boston Scientific Corp (BSX)
    • Perspective Therapeutics Inc (CATX)
    • InfuSystems Holdings Inc (INFU)
    • ResMed Inc (RMD)
    • Stryker Corp (SYK)

Haemonetics Dividend Yield

Data Unavailable

Haemonetics Analyst Estimates

YoY Growth Past Surprise
EPS: -29.83% 0.92%
Revenue: 12.77% 4.2%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 2
Sell Recommendations: 0
Price Target: 113.50
Upside from Last Price: 33.59%

Major Shareholders

  • How many HAE shares are owned by institutional investors?
    90.4M HAE shares are owned by institutional investors
  • How many HAE shares are owned by insiders?
    1.4M HAE shares are owned by insiders